BioPlus Acquisition Corp Valuation
| BIOSWDelisted Stock | USD 0.14 0.00 0.00% |
BioPlus Acquisition seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of BioPlus Acquisition Corp from analyzing the firm fundamentals such as Net Income of 2 M, total debt of 5 M, and Number Of Shares Shorted of 55.25 K as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that BioPlus Acquisition's price fluctuation is very steady at this time. Calculation of the real value of BioPlus Acquisition Corp is based on 3 months time horizon. Increasing BioPlus Acquisition's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the BioPlus stock is determined by what a typical buyer is willing to pay for full or partial control of BioPlus Acquisition Corp. Since BioPlus Acquisition is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BioPlus Stock. However, BioPlus Acquisition's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.14 | Real 0.11 | Hype 0.14 | Naive 0.14 |
The intrinsic value of BioPlus Acquisition's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence BioPlus Acquisition's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of BioPlus Acquisition Corp helps investors to forecast how BioPlus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BioPlus Acquisition more accurately as focusing exclusively on BioPlus Acquisition's fundamentals will not take into account other important factors: BioPlus Acquisition Total Value Analysis
BioPlus Acquisition Corp is currently projected to have takeover price of 0 with market capitalization of 0, debt of 5 M, and cash on hands of 936. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the BioPlus Acquisition fundamentals before making investing decisions based on enterprise value of the companyBioPlus Acquisition Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of BioPlus indicates not a very effective usage of assets in January.BioPlus Acquisition Profitability Analysis
Net Income was 2 M with profit before overhead, payroll, taxes, and interest of 0.About BioPlus Acquisition Valuation
Our relative valuation model uses a comparative analysis of BioPlus Acquisition. We calculate exposure to BioPlus Acquisition's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BioPlus Acquisition's related companies.BioPlus Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in New York, New York. Bioplus Acquisition operates under Shell Companies classification in the United States and is traded on NASDAQ Exchange.
BioPlus Acquisition Growth Indicators
Investing in growth stocks can be very risky. If the company such as BioPlus Acquisition does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 597.8 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in BioPlus Stock
If you are still planning to invest in BioPlus Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioPlus Acquisition's history and understand the potential risks before investing.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |